Table 2.
Study | Publication Year | No. of Patients | Mean or Median Follow-Up (months) | Mean or Median Margin Dose (Gy) | Endocrine Remission (%) |
---|---|---|---|---|---|
Izawa et al45 | 2000 | 12 | 26.4 | 23.8 | 16.7 |
Sheehan et al49 | 2000 | 43 | 39.1 | 20 | 63 |
Shin et al50 | 2000 | 6 | 88.2 | 32.3 | 50 |
Hoybye et al22 | 2001 | 18 | 16.8 | NR | 44 |
Feigl et al19 | 2002 | 4 | 55.2 | 15 | 60 |
Kobayashi et al46 | 2002 | 20 | 64 | 28.7 | 23.3 |
Laws et al47 | 2002 | 40 | NR | 20 | 74 |
Pollock et al48 | 2002 | 9 | 42.4 | 20 | 78 |
Choi et al44 | 2003 | 7 | 42.5 | 28.5 | 55.6 |
Petrovich et al26 | 2003 | 4 | 34 | 15 | NR |
Witt et al52 | 2003 | 8 | 24 | 24 | 0 |
Wong et al53 | 2003 | 5 | 38 | NR | 100 |
Devin et al54 | 2004 | 35 | 42 | 14.7 | 49 |
Kajiwara et al22 | 2005 | 2 | 38.5 | 26 | 50 |
Voges et al41 | 2006 | 17 | 58.7 | 16.4 | 52.9 |
Castinetti et al76 | 2007 | 40 | 54.7 | 29.5 | 42.5 |
Jagannathan et al55 | 2007 | 90 | 45 | 23 | 54 |
Petit et al56 | 2008 | 33 | 62 | 20 | 52 |
Pollock et al57 | 2008 | 8 | 73 | 20 | 87 |
Tinnel et al58 | 2008 | 12 | 37 | 25 | 50 |
Castinetti et al51 | 2009 | 18 | 94 | 28 | 50 |
Kobayashi et al35 | 2009 | 30 | 64.1 | 28.7 | 35 |
Wan et al61 | 2009 | 68 | 67.3 | 23 | 27.9 |
Hayashi et al33 | 2010 | 13 | 36 | 25.2 | 38 |
Sheehan et al60 | 2011 | 82 | 31 | 24 | 54 |
Wein et al62 | 2012 | 17 | 23 | 18 | 58.8 |
Grant et al59 | 2013 | 15 | 40.2 | 35 | 73 |
Abbreviation: NR, not reported.